10/15/2015 - 2:34pm

 Feds are probing the drug maker on drug pricing, distribution and patient assistance programs, according to the Wall Street Journal. “The company’s drug pricing has drawn scrutiny from doctors, hospitals and Democrats in Congress after The Wall Street Journal reported in April about how it and some other companies buy and then significantly raise the prices of drugs,” the report says. (Wall Street Journal, registration required)

10/12/2015 - 7:07am

Upsher-Smith Laboratories was honored Sunday with the National Community Pharmacists Association 2015 Corporate Recognition Award.

10/09/2015 - 10:32am

The New York Times outlines the controversy surrounding the recent FDA approval of Oxycontin in children. “Just because OxyContin has been abused or prescribed inappropriately doesn’t mean we should deprive the children who need the drug,” Kathleen Neville, pediatric oncologist at Arkansas Children's Hospital told The New York Times, adding it is “our obligation to have the best level of evidence for its use in children.” (The New York Times)


10/08/2015 - 10:00am

More than 80% of Americans support medical school and physician residency programs to provide training for physicians in how to treat chronic pain and how to detect and treat addiction to prescription pain medication. 

10/07/2015 - 11:51am

Approximately 4 in 5 U.S. adults in their 40s (80%) and 50s (83%) reported concern around the security of their health data. 

10/07/2015 - 10:32am

More than 260,000 pharmacists have been trained to provide immunization services through APhA, association says. 

10/05/2015 - 12:33pm

So far in 2015, there have bee 221,200 new cases of lung cancer and 158,040 deaths from the illness, according to the National Cancer Institute.

10/05/2015 - 11:22am

Overall, 22% of consumers who are enabling their health management through technology in 2015 vs. 13% two years ago.

10/02/2015 - 11:12am

The company will oversee the drug’s sale, marketing and distribution in the U.S. after acquiring the rights from Pragma Pharmaceuticals.